Evidence map›Paper›PMID 34051350›Full record

ArticleContemporary clinical trials2021

Rationale and methods to characterize the acute exercise response in aging and Alzheimer's Disease: the AEROBIC pilot study.

Zachary D Green, Casey S John, Paul J Kueck, Jeffrey M Burns, Mark Perry, Joseph Donald, Jonathan D Mahnken, Robyn A Honea, Eric D Vidoni, Jill K Morris

Registry-linked trialAbstract read
In one paragraph

Article in Contemporary clinical trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04299308 (Acute Exercise Response On Brain Imaging and Cognition), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04299308 nacompletednot on this map

Acute Exercise Response On Brain Imaging and Cognition

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2020 to 2023Enrolled60ConditionsHealthy Aging, Alzheimer DiseaseArmsAerobic Exercise
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zachary D GreenUniversity of Kansas Alzheimer's Disease Research Center, United States of America; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Casey S JohnUniversity of Kansas Alzheimer's Disease Research Center, United States of America; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Paul J KueckUniversity of Kansas Alzheimer's Disease Research Center, United States of America; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Jeffrey M BurnsUniversity of Kansas Alzheimer's Disease Research Center, United States of America; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Mark PerryDepartment of Radiology, University of Kansas Medical Center, United States of America.
Joseph DonaldDepartment of Radiology, University of Kansas Medical Center, United States of America.
Jonathan D MahnkenUniversity of Kansas Alzheimer's Disease Research Center, United States of America; Department of Biostatistics and Data Science, University of Kansas Medical Center, United States of America.
Robyn A HoneaUniversity of Kansas Alzheimer's Disease Research Center, United States of America; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Eric D VidoniUniversity of Kansas Alzheimer's Disease Research Center, United States of America; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Jill K MorrisUniversity of Kansas Alzheimer's Disease Research Center, United States of America; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America. Electronic address: jmorris2@kumc.edu.

Funding

University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BROOKS, WILLIAM M. · 2011 to 2020
$16.6M
Prescribing Smart Aging: Integrating Health Systems with Community-Based Lifestyle InterventionsR01AG052954 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BURNS, JEFFREY MURRAY · 2017 to 2021
$2.9M
Acute exercise and the cerebral metabolic response in aging and Alzheimer's DiseaseR01AG062548 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MORRIS, JILL KATHLEEN · 2020 to 2024
$2.4M
Relationship of Energetics and Cognitive Trajectory’R00AG050490 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MORRIS, JILL KATHLEEN · 2018 to 2020
$747k
Dementia Risk and Dynamic Response to ExerciseR21AG061548 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI VIDONI, ERIC DENNIS · 2019 to 2020
$383k
NIA NIH HHS P30 AG035982NIA NIH HHS R00 AG050490NIA NIH HHS R01 AG052954NIA NIH HHS R01 AG062548NIA NIH HHS R21 AG061548
6 · The paper itself

Abstract

There is evidence that exercise benefits the brain, but the mechanisms for this benefit are unclear. The chronic benefits of exercise are likely a product of discreet, acute responses in exercise-related blood biomarkers and brain metabolism. This acute exercise response has not been compared in aging and Alzheimer's Disease (AD). It is known that acute exercise elicits a powerful peripheral response in young individuals, and exercise-related biomarkers such as glucose and lactate readily penetrate the brain. How this changes with aging and neurodegenerative disease is less clear. It is critical to characterize and understand the acute effects of exercise, including different exercise intensities, in terms of the peripheral metabolic response and relationship with brain metabolism. This will help determine potential mechanisms for brain benefits of exercise and better inform the design of future clinical trials. The primary goal of the AEROBIC study is to characterize the acute exercise response of brain glucose metabolism and exercise-related blood biomarkers. We will measure how cerebral metabolism is affected by an acute bout of moderate and higher intensity exercise and characterize the extent to which this differs between cognitively healthy older adults and individuals with AD. Related to this primary goal, we will quantify the peripheral biomarker response to moderate and higher intensity exercise and how this relates to brain metabolic change in both groups.

Indexed as

Alzheimer DiseaseNeurodegenerative DiseasesAgedAgingExerciseHumansPilot ProjectsAlzheimer's DiseaseBiomarkerExerciseLactateMetabolism

Identifiers

PMID34051350
PMCPMC8711799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.